31 results
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
, as well as fees paid for legal, accounting and tax services, consulting fees and facilities costs not otherwise included in research and development … -balance sheet arrangements as defined under SEC rules.
Summary of Critical Accounting Policies
Income taxes
We are a C corporation. Deferred tax
8-K
EX-10.1
MIRA
Mira Pharmaceuticals Inc
20 Nov 23
MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2
8:10am
proposed settlement of any such Claim by the other Party might be expected to affect adversely the Indemnitee’s tax status, reputation, the ability
8-K
EX-10.2
MIRA
Mira Pharmaceuticals Inc
20 Nov 23
MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2
8:10am
charge to the Holder for any issue tax or other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses
8-K
EX-10.3
y5ifw2rh vq5pixld3r
20 Nov 23
MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2
8:10am
10-Q
qba9o9cqnokn ygoe
15 Sep 23
Quarterly report
4:45pm
8-K
EX-1.1
x0g9wxo
7 Aug 23
MIRA Pharmaceuticals, Inc. Announces Pricing of $8.9 Million Initial
5:14pm
8-K
EX-4.1
3qofmruq 2rtwyd
7 Aug 23
MIRA Pharmaceuticals, Inc. Announces Pricing of $8.9 Million Initial
5:14pm
424B4
113t7
4 Aug 23
Prospectus supplement with pricing info
1:01pm
424B1
ld03g
4 Aug 23
Prospectus with pricing info
12:59pm